William H. Rastetter holds the role of Director at Dare Bioscience, Inc. (DARE). Rastetter's filing history also covers FATE THERAPEUTICS INC (FATE) and NEUROCRINE BIOSCIENCES INC (NBIX). Rastetter has reported 13 insider filings with the SEC since 2025. The most recent filing was in July 2026.
Every role William H. Rastetter has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Dare Bioscience, Inc. (DARE)2 filingsFATE THERAPEUTICS INC (FATE)1 filingUpdated Aug 30, 2026
William H. Rastetter is Director of Dare Bioscience, Inc. (DARE). 13 SEC Form 4 filings on record going back to 2025, most recently on 2 July 2026. Most recent open-market trade: sold $2.73M of NBIX on 6 November 2025. Lifetime open-market sales: $6.04M.
Every recent SEC Form 4 transaction William H. Rastetter has reported, most recent first.
InsiderAlpha's records for William H. Rastetter go back to 2025: 13 primary Form 4 filings, an average of 6.5 per year. 3 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies William H. Rastetter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
William H. Rastetter is a corporate insider, tracked as Director of Dare Bioscience, Inc. (DARE). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases and 2 open-market sales ($6.04M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$FATE FATE THERAPEUTICS INC25.0K shares @ $1.69$42K